Bio-Rad purchases AbD Serotec for €53m

Published: 22-Jan-2013
Manufacturing Finance Analysis

Adds more than 15,000 antibodies, kits and accessories to life science products


Bio-Rad Laboratories, a multinational manufacturer and distributor of life science research and clinical diagnostic products, has bought AbD Serotec, a division of MorphoSys, for approximately €53m in cash.

AbD Serotec offers more than 15,000 antibodies, kits, and accessories. The company has an ISO 9001 and ISO 13485 certified production facility in Kidlington, near Oxford in the UK, as well as other facilities in Düsseldorf, Germany and Raleigh, NC in the US.

‘We are pleased to have AbD Serotec join Bio-Rad,’ said Norman Schwartz, Bio-Rad’s president and CEO. ‘With AbD Serotec’s comprehensive catalogue of antibodies, we are able to offer our customers total assay solutions that can be validated on many of our research platforms for western blotting, multiplex protein expression, ELISA, and cell sorting.’

Founded in 1952, Bio-Rad is headquartered in Hercules, California, US and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs more than 7,100 people globally and had revenues exceeding US$2bn in 2011.

  • Companies:
  • AbD Serotec
  • Bio-Rad Laboratories
See more

You may also like

Analysis

Bio-Rad expands bispecific antibody generation and screening services for drug development

Read more
The service can allow companies to rapidly screen and generate bispecific antibodies for rapid and effective development

Trending Articles

  1. Lonza Capsules & Health Ingredients expands capsule manufacturing capacity in India and China New capsule manufacturing lines added at Lonza Capsules & Health Ingredients (CHI) facilities in Rewari (IN) and Suzhou (CN), highlighting the long-term strategic commitment to the business and the APAC region
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    How CDMOs can set a new gold standard when it comes to going green Sustainability is more than a feel-good initiative or a choice; it’s a strategic imperative. Not missing a beat, pharma companies have been making a concerted effort towards positive change, reports Tim Lowery, President of JSR Life Sciences and CEO, KBI Biopharma
  3. Novo Holdings completes acquisition of Catalent Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark
  4. Mastering modified-release performance: excipient considerations Imagine a world where enhanced therapeutic efficacy, improved patient compliance and reduced adverse effects are tangible outcomes — even for drugs with short pharmacokinetic (PK) half-lives or narrow therapeutic indices. This is becoming a reality with modified-release (MR) oral delivery systems such as hydrophilic matrix tablets
  5. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Analysis

Bio-Rad expands bispecific antibody generation and screening services for drug development

The service can allow companies to rapidly screen and generate bispecific antibodies for rapid and effective development
Analysis

Bio-Rad launches ChemiDoc Go Imaging System

The system offers rapid, reliable and highly sensitive gel and western blot imaging on a benchtop scale
Manufacturing

Bio-Rad Launches ddSEQ Single-Cell 3' RNA-Seq Kit for Single-Cell Gene Expression

Innovative and affordable solutions for single-cell transcription and gene expression studies
Analysis

Bio-Rad and Oncocyte partner to commercialise transplant monitoring with Droplet Digital PCR

The collaboration aims to provide researchers with tools to enable transformational monitoring of key biomarkers in solid tissue transplants
Analysis

Bio-Rad launches Vericheck ddPCR replication competent AAV and lentivirus kits for cell and gene therapy production

The kits allow for the quantification of replication competent lentivirus and adeno-associated viruses
Analysis

Maximising data quality in digital PCR

Data forms the backbone of all scientific innovation, guiding researchers in their experimental direction and contributing to meaningful conclusions. Marwan Alsarraj, Biopharma Segment Manager, Digital Biology Group, at Bio-Rad reports
Manufacturing

Bio-Rad launches StarBright Blue and StarBright Yellow series

The dyes expand research capabilities across the blue (488 nm) and yellow (561 nm) lasers
Subscribe now